FTSE China 25 Index Fund Ishares (FXI) 40.48

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
FTSE China 25 Index Fund Ishares (FXI) 40.48 $FXI

iShares FTSE Down 16.7% Since SmarTrend Downtrend Call (FXI)
Comtex SmarTrend(R) - Wed Jul 29, 11:50AM CDT
SmarTrend identified a Downtrend for iShares FTSE (NYSE:FXI) on May 7th, 2015 at $49.10. In approximately 3 months, iShares FTSE has returned 16.68% as of today's recent price of $40.91.
FXI: 40.48 (-0.16)

Twitter Earnings on Deck as Investors Digest an Energy Bounce
at The Street - Tue Jul 28, 3:09PM CDT
The CNBC ‘Fast Money’ traders are split on whether energy stocks look attractive or are just prospering from a temporary bounce.
SOCL: 19.03 (-0.18), USO: 15.59 (-0.51), UCO: 27.54 (-1.92), FB: 94.01 (-1.20), GOOG: 625.61 (-6.98), TLT: 122.53 (+0.90), SPY: 210.50 (-0.32), LNKD: 203.26 (-23.89), QQQ: 111.95 (-0.13), DIA: 176.68 (-0.54), GOOGL: 657.50 (-7.06), XLI: 54.22 (-0.05), IWM: 122.96 (+0.67), TWTR: 31.01 (-0.46), IYT: 150.54 (-0.36), XLE: 69.38 (-1.55), FXI: 40.48 (-0.16)

Capture the Shanghai Composite's Popping-Bubble Volatility by Trading This ETF
at The Street - Tue Jul 28, 10:48AM CDT
The Shanghai Composite's popping bubble -- the Crash of 2015 -- is a re-inflation of the bubble that popped from 2007 to 2008. But with volatility comes trading opportunities.
SPY: 210.50 (-0.32), DIA: 176.68 (-0.54), FXI: 40.48 (-0.16)

China Stock Strategy -- Here's How to Profit From the Selloff
at The Street - Tue Jul 28, 9:00AM CDT
Instead of being worried, investors can take advantage of the selloff with exchange traded funds that bet against the Chinese market, also known as bear funds.
YANG: 89.16 (+0.83), YXI: 27.18 (+0.08), ASHR: 39.50 (-0.33), FXI: 40.48 (-0.16), CHAD: 48.60 (+0.61)

After Yesterday's Decline of 3.86%, iShares FTSE Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jul 27, 3:45PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $39.79 to a high of $40.47. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $41.47 on volume of 49.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FXI: 40.48 (-0.16)

4 Big Stocks on Traders' Radars -- and What You Should Do With Them Now
at The Street - Mon Jul 27, 12:14PM CDT
Here's a technical look at how to trade some of the most active stocks on the market right now.
FTR: 4.72 (+0.09), ABX: 7.06 (+0.01), FB: 94.01 (-1.20), FXI: 40.48 (-0.16)

Watch for iShares FTSE to Potentially Rebound After Falling 1.03% Yesterday
Comtex SmarTrend(R) - Wed Jul 22, 3:56PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $42.25 to a high of $42.49. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $42.35 on volume of 11.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FXI: 40.48 (-0.16)

iShares FTSE Shares Down 13.6% Since SmarTrend's Sell Call (FXI)
Comtex SmarTrend(R) - Wed Jul 22, 10:17AM CDT
SmarTrend identified a Downtrend for iShares FTSE (NYSE:FXI) on May 7th, 2015 at $49.10. In approximately 3 months, iShares FTSE has returned 13.62% as of today's recent price of $42.41.
FXI: 40.48 (-0.16)

BUYINS.NET: RIVR, CTCT, HBANP, FXI, CVLT, GXC Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Jul 21, 6:49AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of River Valley Bancorp (NASDAQ:RIVR), Constant Contact Inc (NASDAQ:CTCT), Huntington Bancshares Inc (NASDAQ:HBANP), Ishares Xinhua China 25 (NYSE:FXI), CommVault Systems Inc (NASDAQ:CVLT), SPDR S&P China ETF (NYSE:GXC) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
RIVR: 22.95 (+0.05), HBAN: 11.67 (-0.10), CVLT: 37.47 (-0.13), GXC: 79.30 (-0.37), FXI: 40.48 (-0.16), HBANP: 1,355.00 (+24.95), CTCT: 25.84 (+0.72)

Shanghai Stock Turbulence Will Slow Ticker Trend
at The Street - Thu Jul 16, 3:54PM CDT
Chinese companies listed on U.S. exchanges are rethinking plans to move their tickers back to mainland China, amid the turbulence in the Shanghai stock market.
ASHR: 39.50 (-0.33), FXI: 40.48 (-0.16)

iShares FTSE Falls 2.32% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Jul 15, 4:25PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $41.70 to a high of $42.25. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $42.16 on volume of 31.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FXI: 40.48 (-0.16)

Look for Shares of iShares FTSE to Potentially Rebound after Yesterday's 2.32% Sell Off
Comtex SmarTrend(R) - Wed Jul 15, 4:24PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $41.70 to a high of $42.25. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $42.16 on volume of 31.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FXI: 40.48 (-0.16)

China’s Stock Rally Continues as Foreigners Jump Back In
at The Street - Mon Jul 13, 10:48AM CDT
Valuations that had soared into the double digits are naturally down, an immediate incentive to buy shares.
CAF: 28.38 (+0.13), YINN: 28.36 (-0.30), FXI: 40.48 (-0.16)

iShares FTSE Set to Possibly Pullback After Yesterday's Rally of 4.55%
Comtex SmarTrend(R) - Fri Jul 10, 3:44PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $42.15 to a high of $42.83. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $42.07 on volume of 49.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
FXI: 40.48 (-0.16)

After Yesterday's Rally of 4.55% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Jul 10, 3:44PM CDT
iShares FTSE (NYSE:FXI) traded in a range yesterday that spanned from a low of $42.15 to a high of $42.83. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $42.07 on volume of 49.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
FXI: 40.48 (-0.16)

China May Have Figured Out How to Tame Its Unruly Stock Market
at The Street - Fri Jul 10, 10:49AM CDT
More curbs on margin trading will eventually calm China’s bear market while other relief measures pump money into it, pointing to long-term stability after a month-long fall.
YINN: 28.36 (-0.30), FXI: 40.48 (-0.16)

Two Things Everyone Should Know About Investing in Asia
at The Street - Thu Jul 09, 2:25PM CDT
It may be too late for you to avoid the crash in China, but there's another Asian market you need to watch out for now.
FXI: 40.48 (-0.16)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 270

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 24

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 158

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 152

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 277

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 219

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 263

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 313

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading

Top 5 Most Recently Viewed Articles

Class Action Lawsuit Against Joint Stock Company Kaspi.kz (KSPI)

Updated Category News Views 149

Understanding the Class Action Lawsuit Against Joint Stock Company Kaspi.kz Levi & Korsinsky, LLP has brought to light an important class action lawsuit concerning the Joint Stock Company Kaspi.kz (NASDAQ: KSPI). This initiative aims to provide legal recourse to investors who may have suffered due to alleged fraudulent activities that negatively impacted the company's...

Continue Reading
Verdafero Enhances Emission Reporting for Hospitality Sector

Updated Category News Views 133

Verdafero Launches New Emissions Reporting Service Verdafero, a prominent player in sustainability solutions, has introduced an expanded service for emissions reporting that now includes comprehensive tracking and analysis of Scope 1, Scope 2, and Scope 3 emissions specifically for the hospitality industry. This innovative offering provides businesses in this sector with...

Continue Reading
Analyst Ratings Spark Interest in GE Vernova and Peers

Updated Category News Views 187

Key Analyst Ratings for Prominent Stocks Wall Street analysts have recently begun covering some noteworthy companies, aiming to provide insights for potential investors. Analyst ratings can spark interest in stocks and guide buying decisions, especially when backed by thorough research. This article highlights the initiation of coverage on five significant stocks,...

Continue Reading
Repertoire Immune Medicines and Lilly Team Up on New Therapies

Updated Category News Views 210

Repertoire Immune Medicines and Eli Lilly Announce Collaboration Repertoire Immune Medicines is excited to announce a significant strategic collaboration with Eli Lilly and Company, focusing on the development of tolerizing therapies to treat various autoimmune diseases. This partnership is set to leverage Repertoire's advanced DECODE™ platform, designed to pioneer T...

Continue Reading
Manhattan Associates Faces Lawsuit Amid Significant Losses

Updated Category News Views 1108

Manhattan Associates Faces Lawsuit Amid Significant Losses A class action lawsuit has emerged against Manhattan Associates, Inc. (NASDAQ: MANH), a prominent player in software solutions for supply chain management and inventory operations. This legal action highlights concerns from investors who have experienced notable financial losses stemming from alleged...

Continue Reading